Methods for simultaneous amplification of target loci
AssigneeNatera, Inc.
InventorsMatthew Rabinowitz, Matthew Micah Hill, Bernhard A. Zimmermann, Johan Baner, George Gemelos, Milena Banjevic, Allison Ryan, Styrmir Sigurjonsson, Zachary Demko
Life of this patent
Estimating the term…
Abstract
The invention provides methods for simultaneously amplifying multiple nucleic acid regions of interest in one reaction volume as well as methods for selecting a library of primers for use in such amplification methods. The invention also provides library of primers with desirable characteristics, such as minimal formation of amplified primer dimers or other non-target amplicons.
Claims13
A method for preparing a DNA fraction from a biological sample of a subject useful for analyzing genetic or epigenetic features associated with cancer, comprising:
- (a) extracting cell-free DNA molecules from the biological sample;
- (b) preparing a DNA fraction by:
- introducing at least 1024 adaptors each containing a universal priming sequence and a different molecular barcode into at least a subset of the extracted cell-free DNA molecules to produce a population of adapted DNA molecules, wherein the at least a subset of the extracted cell-free DNA molecules from the biological sample are tagged with at least 1024 different molecular barcodes, performing universal amplification on at least some of the population of adapted DNA molecules using the universal priming sequence to produce a population of amplified adapted DNA molecules, and selectively enriching for at least 1,000 target loci of interest together in the same reaction volume from at least a subset of the population of amplified adapted DNA molecules or its derivative to produce enriched DNA;
- (c) performing massively parallel sequencing on the enriched DNA or its derivative to obtain sequence reads from at least a portion of the target loci of interest;
- (d) identifying from at least a portion of the sequence reads those derived from a same extracted cell-free DNA molecule in the at least a subset of the extracted cell-free DNA molecules using the tagged molecular barcode and forming grouped sequence reads;
- and
- (e) identifying from at least a plurality of the grouped sequence reads one or more genetic or epigenetic features associated with cancer.
Dependencies are inferred from the claim text.